Drug Type TIL therapy |
Synonyms Tumor infiltrating lymphocyte cell therapy Intima Bioscience |
Target- |
Action- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Phase 2 | United States | 15 May 2020 | |
| Esophageal Carcinoma | Phase 2 | United States | 15 May 2020 | |
| Gallbladder Carcinoma | Phase 2 | United States | 15 May 2020 | |
| Metastatic Digestive System Carcinoma | Phase 2 | United States | 15 May 2020 | |
| Pancreatic Cancer | Phase 2 | United States | 15 May 2020 | |
| Stomach Cancer | Phase 2 | United States | 15 May 2020 |





